Abstract
Huntington disease (HD), an autosomal dominant, progressive neurodegenerative disorder, is caused by an expanded CAG repeat sequence leading to an increase in the number of glutamine residues in the encoded protein1. The normal CAG repeat range is 5–36, whereas 38 or more repeats are found in the diseased state; the severity of disease is roughly proportional to the number of CAG repeats1,2,3,4,5. HD shows anticipation, in which subsequent generations display earlier disease onsets due to intergenerational repeat expansion1,2,3,4,5,6. For longer repeat lengths, somatic instability of the repeat size has been observed both in human cases at autopsy7,8 and in transgenic mouse models containing either a genomic fragment of human HD exon 1 (ref. 9) or an expanded repeat inserted into the endogenous mouse gene Hdh (ref. 10). With increasing repeat number, the protein changes conformation and becomes increasingly prone to aggregation11, suggesting important functional correlations between repeat length and pathology. Because dinucleotide repeat instability is known to increase when the mismatch repair enzyme MSH2 is missing12,13,14,15, we examined instability of the HD CAG repeat by crossing transgenic mice carrying exon 1 of human HD (ref. 16) with Msh2–/– mice15. Our results show that Msh2 is required for somatic instability of the CAG repeat.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Huntington Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983 (1993).
Stine, O.C. et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet. 2, 1547–1549 (1993).
Andrew, S.E., Goldberg, Y.P. & Hayden, M.R. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum. Mol. Genet. 6, 2005–2010 (1997).
Duyao, M.P. et al. Inactivation of the mouse Huntington's disease gene homolog hdh. Science 269, 407–410 (1995).
Snell, R.G. et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genet. 4, 393–397 (1993).
Trottier, Y., Biancalana, V. & Mandel, J.L. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J. Med. Genet. 31, 377–382 (1994).
De Rooij, K.E., De Koning Gans, P.A., Roos, R.A., Van Ommen, G.J. & Den Dunnen, J.T. Somatic expansion of the (CAG)n repeat in Huntington disease brains. Hum. Genet. 95, 270–274 (1995).
Telenius, H. et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nature Genet. 6, 409–414 (1994).
Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nature Genet. 15, 197–200 (1997).
Wheeler, V.C. et al. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 8, 115–122 (1999).
Perutz, M.F. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24, 58–63 (1999).
Reitmair, A.H. et al. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts. Cancer Res. 57, 3765–3771 (1997).
Andrew, S.E. et al. Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent. Proc. Natl Acad. Sci. USA 95, 1126–1130 (1998).
Baross-Francis, A., Andrew, S.E., Penney, J.E. & Jirik, F.R. Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc. Natl Acad. Sci. USA 95, 8739–8743 (1998).
de Wind, N., Dekker M., Berns, A., Radman, M. & te Riele, H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82, 321–330 (1995).
Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
Goellner, G.M. et al. Different mechanisms underlie DNA instability in Huntington disease and colorectal cancer. Am. J. Hum. Genet. 60, 879–890 (1997).
Leeflang, E.P. et al. Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: Quantification of the mutation frequency spectrum. Hum. Mol. Genet. 4, 1519–1526 (1995).
Zuhlke, C., Riess, O., Bockel, B., Lange, H. & Thies, U. Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum. Mol. Genet. 2, 2063–2067 (1993).
Giovannone, B. et al. Analysis of (CAG)n size heterogeneity in somatic and sperm cell DNA from intermediate and expanded Huntington disease gene carriers. Hum. Mutat. 10, 458–464 (1997).
Manley, K., Pugh, J. & Messer, A. Instability of the CAG repeat in immortalized fibroblast cell cultures from Huntington's disease transgenic mice. Mol. Brain Res. 835, 74–79 (1999).
Acharya, S. et al. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl Acad. Sci. USA 93, 13629–13634 (1996).
Pearson, C.E., Ewel, A., Acharya, S., Fishel, R.A. & Sinden, R.R. Human MSH2 binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases. Hum. Mol. Genet. 6, 1117–1123 (1997).
Sugawara, N., Paques, F., Colaiacovo, M. & Haber, J.E. Role of Saccharomyces cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced recombination. Proc. Natl Acad. Sci. USA 94, 9214–9219 (1997).
Saparbaev, M., Prakash, L. & Prakash, S. Requirement of mismatch repair genes MSH2 and MSH3 in the RAD1-Rad10 pathway of mitotic recombination in Saccharomyces cerevisae. Genetics 142, 727–736 (1996).
Morgan, L.J. & Taylor, K.E. A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. Mamm. Genome 7, 553–554 (1996).
Kim, S.J. et al. Cloning of novel trinucleotide-repeat (CAG) containing genes in mouse brain. Biochem. Biophys. Res. Commun. 240, 239–243 (1997).
Acknowledgements
We thank H. te Riele for Msh2-deficient mice; the Wadsworth Center Molecular Genetics Core for assistance with the GeneScan analysis; S. Heverly, X. Kang, D. Pierce and K. Tartaglia for expert technical assistance; V. Bolivar for statistical assistance; and D. Nag and T. Petes for helpful discussions. This work was supported by the Hereditary Disease Foundation (Cure HD Initiative), NIH NS37299, NIH DK 52822 and the CDC National Birth Defects Study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manley, K., Shirley, T., Flaherty, L. et al. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat Genet 23, 471–473 (1999). https://doi.org/10.1038/70598
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/70598
This article is cited by
-
Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum
Nature Genetics (2024)
-
Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome
Scientific Reports (2024)
-
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease
Molecular Neurobiology (2024)
-
LUSTR: a new customizable tool for calling genome-wide germline and somatic short tandem repeat variants
BMC Genomics (2024)
-
Dynamic alternative DNA structures in biology and disease
Nature Reviews Genetics (2023)